139 related articles for article (PubMed ID: 35384059)
1. Topography of the orbital part of the lacrimal gland for treating epiphora using botulinum toxin injection.
Shin HJ; You JW; Koh KS; Song WC
Clin Anat; 2022 Oct; 35(7):861-866. PubMed ID: 35384059
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin-B injection into the lacrimal gland and posterior cricoarytenoid muscle for the treatment of epiphora and abductor spasmodic dysphonia secondary to Parkinson's disease.
Sachdev A; Costello D; Madge S
Orbit; 2019 Jun; 38(3):248-251. PubMed ID: 29939826
[TBL] [Abstract][Full Text] [Related]
3. Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing.
Wojno TH
Ophthalmic Plast Reconstr Surg; 2011; 27(2):119-21. PubMed ID: 21224749
[TBL] [Abstract][Full Text] [Related]
4. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
Girard B; Piaton JM; Keller P; Nguyen TH
J Fr Ophtalmol; 2018 Apr; 41(4):343-349. PubMed ID: 29681465
[TBL] [Abstract][Full Text] [Related]
5. Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.
Kaynak P; Karabulut GO; Ozturker C; Fazil K; Arat YO; Perente I; Akar S; Yilmaz OF; Demirok A
Eye (Lond); 2016 Aug; 30(8):1056-62. PubMed ID: 27197871
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
Tu AH; Chang EL
Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
[TBL] [Abstract][Full Text] [Related]
7. Lacrimal gland botulinum toxin injection for epiphora management.
Jeffers J; Lucarelli K; Akella S; Setabutr P; Wojno TH; Aakalu V
Orbit; 2022 Apr; 41(2):150-161. PubMed ID: 34396904
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Effectiveness of Lacrimal Gland Botulinum Toxin Using the TEARS Score.
Hunt SV; Schulz CB; Malhotra R
Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):192-197. PubMed ID: 38427833
[TBL] [Abstract][Full Text] [Related]
9. Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.
Lee AG; Lee SH; Jang M; Lee SJ; Shin HJ
Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33494380
[TBL] [Abstract][Full Text] [Related]
10. [Current clinical application of lacrimal gland injection of botulinum toxin type A in inhibiting lacrimal secretion].
Xu LP; Bai F; Tao H
Zhonghua Yan Ke Za Zhi; 2022 Sep; 58(9):722-726. PubMed ID: 36069098
[TBL] [Abstract][Full Text] [Related]
11. Letter to the editor regarding the article: "Lacrimal gland botulinum toxin injection for epiphora management".
Anderson C; Swan RT; Hill R
Orbit; 2023 Aug; 42(4):468-469. PubMed ID: 36124825
[No Abstract] [Full Text] [Related]
12. Duration of botulinum toxin effect in the treatment of crocodile tears.
Nava-Castañeda A; Tovilla-Canales JL; Boullosa V; Tovilla-y-Pomar JL; Monroy-Serrano MH; Tapia-Guerra V; Garfias Y
Ophthalmic Plast Reconstr Surg; 2006; 22(6):453-6. PubMed ID: 17117101
[TBL] [Abstract][Full Text] [Related]
13. A review on use of botulinum toxin for intractable lacrimal drainage disorders.
Singh S; Ali MJ; Paulsen F
Int Ophthalmol; 2018 Oct; 38(5):2233-2238. PubMed ID: 28766277
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction.
Ziahosseini K; Al-Abbadi Z; Malhotra R
Eye (Lond); 2015 May; 29(5):656-61. PubMed ID: 25744443
[TBL] [Abstract][Full Text] [Related]
15. Lacrimal gland targeted therapies for refractory epiphora: quantitative changes in the gland activity.
Singh S; Bothra N; Ali MJ
Orbit; 2024 Feb; 43(1):74-79. PubMed ID: 37125960
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
Girard B; Piaton JM; Keller P; Abadie C; Nguyen TH
J Fr Ophtalmol; 2017 Oct; 40(8):661-665. PubMed ID: 28847443
[TBL] [Abstract][Full Text] [Related]
17. The use of botulinum toxin A in the treatment of functional epiphora.
Whittaker KW; Matthews BN; Fitt AW; Sandramouli S
Orbit; 2003 Sep; 22(3):193-8. PubMed ID: 12868028
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin injection and tear production.
Alsuhaibani AH; Eid SA
Curr Opin Ophthalmol; 2018 Sep; 29(5):428-433. PubMed ID: 29994851
[TBL] [Abstract][Full Text] [Related]
19. Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment.
Ahn C; Kang S; Sa HS
Eye (Lond); 2019 Jun; 33(6):995-999. PubMed ID: 30765885
[TBL] [Abstract][Full Text] [Related]
20. Transconjunctival botulinum toxin injection into the lacrimal gland in crocodile tears syndrome.
Pattanayak S; Sharma PK; Samikhya S; Khuntia I; Patra K
Indian J Ophthalmol; 2022 Apr; 70(4):1339-1342. PubMed ID: 35326051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]